2nd International Conference and Exhibition on Cell & Gene Therapy to be held during October 23-25 2013, at Orlando-FL, USA.

LOS ANGELES, CA, USA, August 2, 2013 /EINPresswire.com/ -- Cell Therapy and Gene Therapy are two different fields of biomedical research that often overlaps with similar therapeutic goals. If DNA is inserted to fight an acquired or inherited disease, Cell Transplantation takes place in ‘Cell therapy’ to fight diseases. Although both the methods have been deployed for the past three decades, technological advancements in the medical field are opening up variety of opportunities to cancers of all kind effectively.

Following methods are widely used in both Cell and Gene Therapy:
• Gene drugs are delivered directly into the tumor to kill Cancer
• Cell and gene Vaccines are injected to resist or destroy Cancer
• Cell and Gene Therapeutics are used to target a particular stem cell to destroy cancer.
• Gene therapy is used to smother the cancer cell by cutting of the blood supply.

Cell Therapy-2013: OMICS Group takes pride in inviting all the participants across the globe to attend the 2nd International Conference and Exhibition on Cell & Gene Therapy to be held during October 23-25 2013, at Orlando-FL, USA.

Following the success of the 1st International Conference on Emerging Cell Therapies, OMICS group calls for yet another venture in this area.

Cell Therapy-2013 is a remarkable event which brings together a unique and International mix of leading Universities and cell therapy institutions making the Congress a perfect platform to share experience.
It serve as a catalyst for the advancement in cell & gene therapies by connecting scientists within and across disciplines at conferences held under a single roof that create an environment conducive to information exchange, generation of new ideas and acceleration of applications that benefit society.

Reputed speakers that are part of the event are:

• Jagat R. Kanwar, Deakin University Australia
• Kapil Bharti, National Institutes of Health USA
• Paul L Hermonat, Central Arkansas Veterans Healthcare System, USA
• Joseph Pastore, Juventas Therapeutics, USA
• Hilal Arnouk, Cell Constructs, Inc, USA
• Paul D. Robbins, The Scripps Research Institute, USA
• Valentin Fulga, Hemostemix, Canada
• Karim Nayernia, Co-Director of Institute of Molecular Medicine and Cell Therapy, Germany

Major Tracks of the Conference Include

• Cell & Gene Therapy- Potential Applications
• Stem Cell Therapies
• Cellular Therapies
• Advanced Gene Therapeutics
• Immunotherapy
• Cancer Therapies
• Nano-Therapy
• Bioengineering Therapeutics
• Clinical Trials and Research in Cell & Gene Therapies
• Regulatory & Ethical Issues of Therapies

Workshop
Parallel to conference, Igor I. Katkov, Ph. D, Chief Scientific Officer and Founder, Celltronixs holds a workshop on "Cryopreservation and High Temperature Biostabilazation of cell and Gene Therapy".

For more details on Cell Therapy-2013 Conference, please visit:
http://www.omicsgroup.com/conferences/cell-gene-therapy-2013/

For further details contact
Sharan Daniel
Cell Therapy-2013 Organizing Committee
Medical Conferences
5716 Corsa Ave., Suite 110
Westlake, Los Angeles, CA 91362-7354, USA
Phone: +1-650-268-9744
Fax: +1-650-618-1414
Toll free: +1-800-216-6499
E-mail: celltherapy2013@omicsgroup.info
celltherapy2013@omicsgroup.us

Sharan Daniel
OMICS Group Incorporation
+1- 650-268-9744
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.